This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

National Research Corporation Announces Second Quarter 2014 Results

LINCOLN, Neb., Aug. 5, 2014 (GLOBE NEWSWIRE) -- National Research Corporation (Nasdaq:NRCIA) (Nasdaq:NRCIB) today announced results for the second quarter of 2014.
  • Net New Sales $4.1 million
  • Total Contract Value $99.5 million
  • Revenue up 7% to $24.0 million
  • Net Income of $4.1 million, up 18%

Remarking on company performance, Michael D. Hays, Chief Executive Officer of National Research said, "Net new sales are up 25% from last quarter and looking ahead at new sales for the last half of the year, suggests recent changes made appear sustainable."

Revenue for the quarter ended June 30, 2014, was $24.0 million, compared to $22.4 million for the same quarter in 2013. Net income for the quarter ended June 30, 2014, was $4.1 million, compared to $3.4 million for the quarter ended June 30, 2013. Diluted earnings per share increased to $0.10 for Class A shares and $0.57 for Class B shares for the quarter ended June 30, 2014, from diluted earnings per share of $0.08 for Class A shares and $0.49 for Class B shares for the quarter ended June 30, 2013. Combined diluted earnings per share (a non-GAAP measure) increased to $0.16 for the quarter ended June 30, 2014, from $0.14 for the second quarter of 2013.

Regarding second quarter performance, Kevin Karas, Chief Financial Officer of National Research, said, "The positive trend of double-digit revenue growth continued in our Acute Care Experience (17%), Market Insights (13%), and Connect (23%) offerings . From an earnings standpoint, we continue to enjoy leverage on incremental revenue, which resulted in net income growth by 18% for the quarter."

A listen-only simulcast of the National Research 2014 second quarter conference call will be available online at on August 6, 2014, beginning at 11:00 a.m. Eastern time. The online replay will follow approximately one hour later and continue for 30 days.

For more than 33 years, National Research Corporation has been at the forefront of patient-centered care, helping healthcare providers measure and improve quality and services through analytics that offer a rich understanding of customers' experiences, preferences, risks, and behaviors across the healthcare continuum.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.01 1.05%
FB $99.75 -4.15%
GOOG $682.74 -0.12%
TSLA $147.99 -8.99%
YHOO $27.05 -3.29%


Chart of I:DJI
DOW 16,027.05 -177.92 -1.10%
S&P 500 1,853.44 -26.61 -1.42%
NASDAQ 4,283.7530 -79.3910 -1.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs